{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:40:19Z","timestamp":1790912419991,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,28]]},"abstract":"<jats:p>A potential breakthrough in the fight against malaria is the availability of a new promising tool, the R21\/Matrix-M\u2122 malaria vaccine that has shown an efficacy of 75% to protect young children against clinical malaria in different epidemiological settings. WHO recommends its deployment in addition to RTS,S\/ASO1 and other effective interventions.<\/jats:p>","DOI":"10.1093\/jtm\/taad140","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T16:27:57Z","timestamp":1699806477000},"source":"Crossref","is-referenced-by-count":36,"title":["R21\/Matrix-M\u2122 malaria vaccine: a new tool to achieve WHO\u2019s goal to eliminate malaria in 30 countries by 2030?"],"prefix":"10.1093","volume":"30","author":[{"given":"Blaise","family":"Genton","sequence":"first","affiliation":[{"name":"Travel and Tropical Diseases Policlinic , Center for Primary Care and Public Health (Unisant\u00e9), , Lausanne, Switzerland"},{"name":"University of Lausanne , Center for Primary Care and Public Health (Unisant\u00e9), , Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"key":"2023122906163313600_ref1"},{"key":"2023122906163313600_ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"2023122906163313600_ref3","author":"Malaria Vaccine Funders Group"},{"key":"2023122906163313600_ref4"},{"key":"2023122906163313600_ref5","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci Rep"},{"key":"2023122906163313600_ref6","first-page":"469","article-title":"Looking ahead in malaria: R21\/Matrix-M\u2122, an exciting new vaccine candidate","volume":"103","author":"Datoo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2023122906163313600_ref7","first-page":"594","article-title":"High level efficacy in humans of a next-generation Plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant","volume":"97","author":"Venkatraman","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2023122906163313600_ref8","first-page":"226","article-title":"A Phase Ib, open-label, age de-escalation, dose escalation study to evaluate the safety and tolerability of different doses of a candidate malaria vaccine adjuvanted R21 (R21\/MM) in adults, young children and infants in Kilifi, Kenya","volume":"103","author":"Njau","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2023122906163313600_ref9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"2023122906163313600_ref10","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/Matrix-M\u2122 vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023122906163313600_ref11","article-title":"A phase III randomised controlled trial evaluating the malaria vaccine 1 candidate R21\/Matrix-M\u2122\u2122 in African children","author":"Datoo","journal-title":"Lancet"},{"key":"2023122906163313600_ref12","first-page":"61","article-title":"Malaria Vaccine: WHO position paper. Weekly epidemiological record","year":"2022"},{"key":"2023122906163313600_ref13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria- exposed adults in Mali: a randomised, double-blind phase 1 trial","volume":"17","author":"Sissoko","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taad140\/54136499\/taad140.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/8\/taad140\/54913876\/taad140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/8\/taad140\/54913876\/taad140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T06:16:47Z","timestamp":1703830607000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taad140\/7413192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":13,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,11,11]]},"published-print":{"date-parts":[[2023,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taad140","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,11,11]]},"article-number":"taad140"}}